Term ends Oct 28, 2031 · Medium confidence
20-year base term ends Nov 4, 2031
Why Medium: The disclaimer's references carry disclaimers of their own not yet read (US 10,583,190), so the cap could be lower.
Nov 4, 2011
Oct 28, 2031
Jul 30, 2019
This patent's term runs 41 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 1 of 3 maintenance fees is paid so far. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Nov 4, 2011, when application PCT/EP2011/069476, the earliest non-provisional in its chain, was filed (this one was filed Jul 20, 2017) | Nov 4, 2031 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +41 days, USPTO patent term adjustment record | Dec 15, 2031 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,583,190, US 11,278,618, US 9,717,791) | capped to Oct 28, 2031 | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Oct 28, 2031 | Medium confidence |
This family
| US 9,744,234 | In force May 2033 | May 2033 |
| US 10,363,307 | this patent Oct 2031 | Oct 2031 |
| Application 16/439,423 | Abandoned not computed | not computed |
| US 11,534,491 | In force Mar 2032 | Mar 2032 |
| Application 17/127,758 | Abandoned not computed | not computed |
| Application 17/165,729 | Abandoned not computed | not computed |
| US 12,465,635 | In force Oct 2031 | Oct 2031 |
| Application 18/048,797 | Abandoned not computed | not computed |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Dec 18, 2018 Reel 47802, frame 666 | Machacek, Matthias | Novartis Pharma AG | Assignment of Assignor's Interest |
| Dec 18, 2018 Reel 47802, frame 777 | Mpofu, Shephard; Richards, Hanno; Thangavelu, Karthinathan | Novartis AG | Assignment of Assignor's Interest |
| Dec 18, 2018 Reel 47802, frame 828 | Novartis Pharma AG | Novartis AG | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 10,583,190, US 11,278,618, US 9,717,791.